Blood Safety Initiative: Extension of Comment Period on Proposed Rules and Announcement of Public Meeting

Samenvatting

The Food and Drug Administration (FDA) is announcing a public meeting and is extending to December 22, 1999, the comment period on two proposed rules entitled ``Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicable Disease Agents,'' and ``General Requirements for Blood, Blood Components, and Blood Derivatives; Notification of Deferred Donors.'' FDA is also extending to December 22, 1999, the comment period on the advance notice of proposed rulemaking (ANPRM) entitled ``Plasma Derivatives and other Blood-Derived Products; Requirements for Tracking and Notification.'' The purpose of the meeting is to provide a public forum for gathering information and views regarding the proposed rules and the ANPRM. The comment periods are being extended to provide time for the submission of comments that may result from the issues discussed at the public meeting.